Comments on: Emisphere Highlights Eligen Licensee Novo Nordisk’s Entry into Phase 3A Development of Oral Semaglutide /contractors/drug-delivery/emisphere-technologies/pressreleases/pressemisphere-novo-nordisks-phase-3a-development-oral-semaglutide/ The leading site for news and procurement in the pharmaceutical industry Fri, 23 Oct 2015 03:28:00 +0000 hourly 1 https://wordpress.org/?v=6.7.2